Monday, August 31, 2026

Everbridge Stock Bearish Momentum With A 9% Slide So Far On Friday

Everbridge Stock Bearish Momentum With A 9% Slide So Far On Friday

(VIANEWS) - Shares of Everbridge (NASDAQ: EVBG) slid 9.85% to $27.38 at 11:48 EST on Friday, after two sequential sessions in a row of losses. NASDAQ is falling 0.15% to $12,041.77, following the last session's downward trend. This seems, up until now, a somewhat negative trend trading session today.

Everbridge's last close was $30.37, 40.22% under its 52-week high of $50.80.

About Everbridge

Everbridge, Inc. operates as a software company that enables customers to anticipate, mitigate, respond to, and recover from critical events in North America and internationally. The company offers Critical Event Management, a SaaS based platform, which offers various software applications for organizations for safeguarding business operations, people resilience, digital operations, smart security, and public safety. The Company's enterprise applications include Mass Notification, Safety Connection, IT Alerting, Visual Command Center, Public Warning, Community Engagement, Risk Center, Crisis Management, CareConverge, Control Center, 911 Connect, Travel Risk Management, SnapComms, and E911 for automating various critical event management processes. It serves enterprises, small businesses, non-profit organizations, educational institutions, and government agencies in technology, energy, financial services, healthcare and life sciences, manufacturing, media and entertainment, retail, higher education, and professional services industries. The company was formerly known as 3n Global, Inc. and changed its name to Everbridge, Inc. in April 2009. The company was founded in 2002 and is based in Burlington, Massachusetts.

Earnings Per Share

As for profitability, Everbridge has a trailing twelve months EPS of $-1.73.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -16.27%.

Growth Estimates Quarters

The company's growth estimates for the present quarter and the next is 750% and 966.7%, respectively.

Moving Average

Everbridge's worth is way below its 50-day moving average of $32.98 and way below its 200-day moving average of $31.79.

Yearly Top and Bottom Value

Everbridge's stock is valued at $27.38 at 11:48 EST, way below its 52-week high of $50.80 and way above its 52-week low of $24.10.

Volatility

Everbridge's last week, last month's, and last quarter's current intraday variation average was a negative 1.23%, a negative 0.35%, and a positive 2.73%.

Everbridge's highest amplitude of average volatility was 2.06% (last week), 2.30% (last month), and 2.73% (last quarter).

More news about Everbridge (EVBG).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise AI's Trust Gap: Microsoft-Mistral Ecosystem Expansion Meets a Governance Deficit in Agentic Adoption
Microsoft is deepening its AI platform bet through simultaneous moves — expanding its Mistral partnership (Copilot Studio, Foundry, European infrastructure capacity) and deepening enterprise AI governance ties with Manulife — just as independent research (Google Cloud, VentureBeat, Box) shows enterprises racing toward agentic AI adoption (100% planned within two years) while data access and trust in agent decisions lag badly (average 45% data access, only ~half trust agent outputs). The result is a structural mismatch between platform-vendor momentum and enterprise readiness to actually govern and trust the agents being deployed.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
Same entity (Morgan Stanley & Co. LLC), same metric (net_income), same fiscal period (Q1 2026), same observation date (2026-03-31), but vastly different values: $5.567 billion vs. $5.57. These cannot coexist for the same time period. Fact B appears to be a data entry error (possible missing decimal placement: 5.57 should likely be 5,567,000,000 or a per-share figure incorrectly entered as total).
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,257 source documents archived
Query this data → isubstrate.com